Shorter tuberculosis treatment for people without symptoms
Part of Infections clinical trials.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 80 years old
- You have TB bacteria confirmed in a sample from your lungs (sputum, lung fluid, or tissue)
- You have not had TB symptoms (like cough for more than 2 weeks, night sweats, fever, or weight loss) in the past 3 months
- You have not been treated for TB for more than 1 week in the last 6 months
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control
- You do not have severe liver disease, low blood counts, or certain drug-resistant TB
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study is testing whether a shorter course of TB medicine works just as well as the standard longer treatment for children with drug-susceptible tuberculosis. It aims to make treatment easier for families.
This study tests a shorter, all-oral treatment for people with Rifampicin-resistant TB. It aims to see if a new combination of drugs works well and safely over a shorter time.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests a shorter treatment course (instead of the standard 6 months) for people with low-risk active TB in the lungs. It aims to see if the shorter regimen works just as well and has fewer side effects.
This trial tests if a shorter treatment course works as well as the standard one for people whose chest X-rays suggest TB but whose sputum tests are negative. It aims to make treatment easier for patients.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.